Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit - PubMed (original) (raw)
Comparative Study
Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit
H Y Wu et al. Infect Immun. 1993 Jan.
Abstract
The level and distribution of isotype-specific antibodies in various secretions and of antibody-secreting cells in corresponding lymphoid organs and tissues were compared in mice immunized with Streptococcus mutans surface protein antigen I/II (AgI/II) conjugated to the cholera toxin B subunit (CTB), given intranasally (i.n.) or intragastrically (i.g.), with or without free cholera toxin (CT) as an adjuvant. Immunization i.n. induced stronger initial antibody responses to AgI/II in both serum and saliva than immunization i.g., but salivary immunoglobulin A (IgA)-specific antibody responses to immunization about 3 months later were not increased relative to total salivary IgA concentrations. Specific antibodies induced by i.n. immunization were as widely distributed in serum, saliva, tracheal wash, gut wash, and vaginal wash as those induced by i.g. immunization. Likewise, specific antibody-secreting cells were generated in the spleen, salivary glands, intestinal lamina propria, and mesenteric and cervical lymph nodes by either route of immunization. The strongest salivary IgA antibody response was induced by AgI/II-CTB conjugate given i.n., but the addition of CT did not further enhance it. However, free CTB could effectively replace CT as an adjuvant in i.n. immunization with unconjugated AgI/II. Booster i.n. immunization with AgI/II plus either free CT or CTB induced stronger recall serum antibody responses than conjugated AgI/II-CTB with or without CT as an adjuvant. Therefore, i.n. immunization with a protein antigen and free or coupled CTB is an effective means of generating IgA antibody responses expressed at several mucosal sites where protective immunity may be beneficial.
Similar articles
- Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.
Wu HY, Russell MW. Wu HY, et al. Vaccine. 1998 Jan-Feb;16(2-3):286-92. doi: 10.1016/s0264-410x(97)00168-0. Vaccine. 1998. PMID: 9607044 - Mucosal vaccines based on the use of cholera toxin B subunit as immunogen and antigen carrier.
Lebens M, Holmgren J. Lebens M, et al. Dev Biol Stand. 1994;82:215-27. Dev Biol Stand. 1994. PMID: 7958476 Review. - Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM. Holmgren J, et al. Am J Trop Med Hyg. 1994;50(5 Suppl):42-54. Am J Trop Med Hyg. 1994. PMID: 8203723 Review.
Cited by
- Oral Immunization of Chickens With Recombinant Lactobacillus plantarum Vaccine Against Early ALV-J Infection.
Wang S, Geng N, Zhou D, Qu Y, Shi M, Xu Y, Liu K, Liu Y, Liu J. Wang S, et al. Front Immunol. 2019 Oct 2;10:2299. doi: 10.3389/fimmu.2019.02299. eCollection 2019. Front Immunol. 2019. PMID: 31632395 Free PMC article. - Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis.
Yang QB, Martin M, Michalek SM, Katz J. Yang QB, et al. Infect Immun. 2002 Jul;70(7):3557-65. doi: 10.1128/IAI.70.7.3557-3565.2002. Infect Immun. 2002. PMID: 12065496 Free PMC article. - Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.
Gupta S, Janani R, Bin Q, Luciw P, Greer C, Perri S, Legg H, Donnelly J, Barnett S, O'Hagan D, Polo JM, Vajdy M. Gupta S, et al. J Virol. 2005 Jun;79(11):7135-45. doi: 10.1128/JVI.79.11.7135-7145.2005. J Virol. 2005. PMID: 15890953 Free PMC article. - Lymphotoxin plays a crucial role in the development and function of nasal-associated lymphoid tissue through regulation of chemokines and peripheral node addressin.
Ying X, Chan K, Shenoy P, Hill M, Ruddle NH. Ying X, et al. Am J Pathol. 2005 Jan;166(1):135-46. doi: 10.1016/S0002-9440(10)62239-0. Am J Pathol. 2005. PMID: 15632007 Free PMC article. - Immunopathogenesis of recurrent vulvovaginal candidiasis.
Fidel PL Jr, Sobel JD. Fidel PL Jr, et al. Clin Microbiol Rev. 1996 Jul;9(3):335-48. doi: 10.1128/CMR.9.3.335. Clin Microbiol Rev. 1996. PMID: 8809464 Free PMC article. Review.
References
- Immunol Today. 1992 Jun;13(6):219-24 - PubMed
- Scand J Immunol. 1991 Jun;33(6):691-8 - PubMed
- Immunology. 1992 Nov;77(3):443-8 - PubMed
- J Anat. 1971 Sep;109(Pt 3):369-83 - PubMed
- J Immunol Methods. 1984 Feb 24;67(1):101-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous